Radiation-Free Bone Health Assessment Global Market Report 2026

Radiation-free bone health assessment is a diagnostic method that measures bone mineral density and evaluates bone quality without exposing patients to ionizing radiation, primarily through technologies such as quantitative ultrasound (QUS) and radiofrequency echographic multi-spectrometry (REMS). These techniques provide a safe and non-invasive approach for assessing peripheral or axial skeletal regions, enabling regular monitoring of bone health and osteoporosis risk, particularly for children, pregnant women, and individuals requiring repeated evaluations.

The primary offerings within radiation-free bone health assessment include services and products. Services refer to diagnostic and assessment solutions that examine bone health using non-ionizing technologies to evaluate bone quality, density, and fracture risk without exposing patients to radiation. These solutions employ technologies such as quantitative ultrasound, radiofrequency echographic multi-spectrometry, and artificial intelligence-enabled bone health analysis software, and they are performed at axial sites including the hip and spine as well as peripheral sites such as the heel, radius, tibia, and finger. They are designed for age groups including the pediatric population, adults, the geriatric population, and pregnant women, and they are utilized by end users such as hospitals and specialty clinics, primary care and diagnostic chains, public health programs, and occupational and corporate wellness programs.

Tariffs are influencing the radiation-free bone health assessment market by increasing expenses for imported quantitative ultrasound systems, REMS scanners, portable bone assessment devices, sensors, and diagnostic software components. This is delaying equipment procurement and slowing the expansion of screening programs, particularly in regions dependent on imported medical devices such as Asia-Pacific and Latin America. Technology-driven categories including quantitative ultrasound devices, radiofrequency echographic multi spectrometry systems, portable bone health assessment devices, and bone health analysis software are experiencing the greatest impact because of global supply chain dependence. Nevertheless, tariffs are encouraging domestic manufacturing, regional supplier diversification, and stronger investment in local diagnostic device production, supporting greater long-term resilience across the market.

The radiation-free bone health assessment market research report is one of a series of new reports from The Business Research Company that provides radiation-free bone health assessment market statistics, including radiation-free bone health assessment industry global market size, regional shares, competitors with a radiation-free bone health assessment market share, detailed radiation-free bone health assessment market segments, market trends and opportunities, and any further data you may need to thrive in the radiation-free bone health assessment industry. This radiation-free bone health assessment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiation-free bone health assessment market size has grown strongly in recent years. It will grow from $0.16 billion in 2025 to $0.17 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of osteoporosis, increasing awareness of preventive bone health screening, growing aging population, expanding utilization of non invasive diagnostic technologies, increasing focus on early detection of bone disorders.

The radiation-free bone health assessment market size is expected to see strong growth in the next few years. It will grow to $0.22 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to growing adoption of portable bone assessment systems, increasing demand for radiation free diagnostic solutions, expanding public health screening initiatives, rising investment in preventive healthcare programs, increasing utilization of bone health monitoring services. Major trends in the forecast period include growing adoption of radiation free bone density screening, increasing use of portable bone health assessment devices, rising demand for frequent osteoporosis monitoring, expansion of community based bone health screening programs, growing preference for non invasive bone quality assessment.

The rising prevalence of osteoporosis and osteopenia is anticipated to drive the growth of the radiation-free bone health assessment market in the forecast period. Rising prevalence of osteoporosis and osteopenia refers to the growing number of individuals experiencing decreased bone mineral density, ranging from early-stage bone loss (osteopenia) to advanced bone weakening (osteoporosis), which increases the likelihood of fractures. The growing prevalence of osteoporosis and osteopenia is attributed to factors such as an aging population, an increasing postmenopausal population, inactive lifestyles, nutritional deficiencies, and the rising impact of chronic diseases that negatively affect bone health. With the increasing number of individuals vulnerable to fractures and bone-related complications, the demand for early diagnosis, regular bone density monitoring, and preventive healthcare interventions is also increasing, supporting the adoption of radiation-free bone health assessment technologies. For instance, in May 2024, according to the Bone Health And Osteoporosis Foundation (BHOF), a US-based nonprofit organization, around 10 million Americans were affected by osteoporosis, while another 44 million Americans had low bone density (osteopenia), increasing their risk of fractures. Therefore, the rising prevalence of osteoporosis and osteopenia is supporting the growth of the radiation-free bone health assessment market.

Key companies operating in the radiation-free bone health assessment market are focusing on expanding access to point-of-care osteoporosis screening through strategic partnerships and the implementation of radiation-free ultrasound technologies. Point-of-care osteoporosis screening enables rapid and non-invasive bone health evaluations in community and primary care settings, supporting early osteoporosis risk identification and timely preventive interventions. For example, in May 2026, Bone Index Finland Oy, a Finland-based medical technology company specializing in radiation-free bone density assessment solutions, partnered with Boots, a UK-based pharmacy-led healthcare and retail company, to launch a pilot Bone Density Scan Service using Bindex ultrasound technology at selected Boots pharmacies. The initiative aimed to improve access to early osteoporosis risk assessment through radiation-free, point-of-care screening in community healthcare settings. The pilot program was designed to integrate bone health screening into routine pharmacy services, enabling individuals to undergo a quick assessment without requiring a hospital visit. The collaboration sought to support earlier identification of individuals at risk of low bone mineral density, allowing timely referral for further clinical evaluation when appropriate. By expanding access to convenient community-based screening, the initiative aimed to increase public awareness of osteoporosis and encourage proactive bone health management.

In November 2024, Echolight S.p.A., an Italy-based medical technology company focused on radiation-free bone densitometry solutions, entered into a partnership with Siemens Healthineers. Through this collaboration, Siemens Healthineers broadened the availability of Echolight's REMS-based bone densitometry systems in the US market, supporting the growing adoption of radiation-free technologies for bone health evaluation. Siemens Healthineers is a Germany-based medical technology company.

Major companies operating in the radiation-free bone health assessment market report are Echolight S.p.A., Esaote S.p.A., Furuno Electric Co. Ltd., OsteoSys Co. Ltd., BeamMed Ltd., Bone Index Finland Oy, CHISON Medical, SIUI (Shantou Institute of Ultrasonic Instruments Co. Ltd.), Alpinion Medical Systems Co. Ltd., Trivitron Healthcare, Vinno Technology Co. Ltd., Bone Health Screening Ltd, Precision Bone Imaging LLC, CyberLogic Inc., CompuMed Inc., Medonica Co. Ltd., POROUS GmbH

Western Europe was the dominant region in the radiation-free bone health assessment market in 2025. North America is expected to be the rapidly growing region in the forecast period. The regions covered in the radiation-free bone health assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiation-free bone health assessment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiation-free bone health assessment market consists of revenues earned by entities providing services such as bone mineral density (BMD) screening, osteoporosis risk assessment, preventive bone health screening, bone health monitoring and follow-up, and mobile and community-based bone health screening. The market value includes the value of related goods sold by the service provider or included as part of the service offering. The radiation-free bone health assessment market also includes sales of radiation-free bone assessment devices, portable bone densitometry systems, and wireless bone assessment devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiation-Free Bone Health Assessment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses radiation-free bone health assessment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiation-free bone health assessment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiation-free bone health assessment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Offering: Services; Products
• 2) By Technology: Quantitative Ultrasound; Radiofrequency Echographic Multi Spectrometry; Artificial Intelligence Enabled Bone Health Analysis Software
• 3) By Site Of Assessment: Axial Sites Hip And Spine; Peripheral Sites Heel Radius Tibia Finger
• 4) By Age Group: Pediatric Population; Adults; Geriatric Population; Pregnant Women
• 5) By End User: Hospitals And Specialty Clinics; Primary Care And Diagnostic Chains; Public Health Programs; Occupational And Corporate Wellness Programs
• Subsegments:
• 1) By Services: Bone Mineral Density Screening Services; Osteoporosis Risk Assessment Services; Preventive Bone Health Screening Services; Bone Health Monitoring And Follow Up Services; Mobile And Community Based Screening Services
• 2) By Products: Quantitative Ultrasound Bone Densitometers; Radiofrequency Echographic Multi Spectrometry Bone Scanners; Portable Bone Health Assessment Devices; Bone Health Analysis Software; Wireless Bone Assessment Systems
• Companies Mentioned: Echolight S.p.A.; Esaote S.p.A.; Furuno Electric Co. Ltd.; OsteoSys Co. Ltd.; BeamMed Ltd.; Bone Index Finland Oy; CHISON Medical; SIUI (Shantou Institute of Ultrasonic Instruments Co. Ltd.); Alpinion Medical Systems Co. Ltd.; Trivitron Healthcare; Vinno Technology Co. Ltd.; Bone Health Screening Ltd; Precision Bone Imaging LLC; CyberLogic Inc.; CompuMed Inc.; Medonica Co. Ltd.; POROUS GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.